Loading company
Sophia Genetics SA
SOPH · Nasdaq · ·
Next earnings: November 3, 2026
$8.29-2.5%Sep 29 close
- 1M
- -1.6%
- 6M
- +62.9%
- 1Y
- +86.3%
- 5Y
- -50.5%
Sophia Genetics SA is the 20th largest of 41 graded companies. Showing 5 of them, including SOPH itself.
| Company | Grade | Market value | Revenue | Profit margin | Free cash flow | Price to earnings |
|---|---|---|---|---|---|---|
| Talkspace, Inc.TALK | D | — | $245.7M | 0.1% | — | — |
| Veeva Systems Inc.VEEV | A+ | $45.1B | $3.5B | 29.3% | — | 45.59 |
| Tempus AI, Inc.TEM | D- | $14.8B | $1.4B | -17.8% | -$263.2M | — |
| BrightSpring Health Services, Inc.BTSG | A | $11B | $14.4B | 2.5% | $402.4M | 33.55 |
| Sophia Genetics SASOPH | B- | $567.8M | $77.3M | -102.2% | -$36.5M | — |
36 more health information services companies
Graded on the same five checks, from their own SEC filings.
A blank price-to-earnings means a loss, not a missing figure — the ratio has no meaning when there are no earnings to divide by, and printing a negative one would make the least profitable company look the cheapest.
Grades are trailing twelve months from each company’s own SEC filings, so they move only when a company files. Every column is computed by the same code that graded Sophia Genetics SA on the overview — nothing here comes from a data vendor’s own ratios.
Industry membership is not a judgement about how similar two businesses are. It groups companies by what they are classified as, which is a starting point for comparison rather than a claim that they compete.
SOPH · Nasdaq · ·
Next earnings: November 3, 2026
$8.29-2.5%Sep 29 close